In August, Cardinal Health launched its next-generation NTrainer System 2.0. The medical device is expected to help in reducing the neonatal intensive care unit (NICU) length of stay for premature and newborn infants. Société Générale's top U.S. equity strategist has lifted his S&P 500 target for 2023, saying investors want to buy growth and industrials.

One share of CAH stock can currently be purchased for approximately $87.94. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation. Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions, expanding connections between payers and pharma to… Medical products maker Cardinal Health is combining its Outcomes business with pharmacy tech firm Transaction Data Systems.

HCA Healthcare Inc

Compare
CAH’s historical performance
against its industry peers and the overall market. Cardinal Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.21%), State Street Corp (5.93%), Geode Capital Management LLC (2.13%), Acadian Asset Management LLC (1.39%), Northern Trust Corp (1.30%) and Pacer Advisors Inc. (1.19%). Insiders that own company stock include Deborah Weitzman, Jessica L Mayer, Mary C Scherer, Michelle Brennan, Ola M Snow and Stephen M Mason.

Revenue increased 13% to $50.5 billion GAAP1 operating earnings were $572 million; GAAP diluted EPS was $1.34 Non-GAAP operating earnings increased 11% to $606 million; non-GAAP diluted EPS increased … Cardinal Health, a manufacturer and distributor of medical and laboratory products, has teamed up with Square to provide payment solutions for independent pharmacies. New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth DUBLIN, Ohio , June 15, 2023 /PRNewswire/ — Cardinal Health … Data are provided 'as is' for informational purposes only and are not intended for trading purposes.

Cathie Wood Continues To Unload DraftKings Shares, Picks Up Robinhood Stock Worth $4.75M

During the fiscal fourth quarter, CAH launched its Navista Network — a specific suite of offering for community oncologists. Moreover, the company merges its Outcomes service with BlackRock’s transaction data system, creating opportunity for pharmacies’ growth. The Medical segment’s sales are being primarily driven by robust demand for at-home solutions as well as an improvement in pricing for products. Moreover, cost optimizing measures have helped the company improve margins for the segment during the last reported quarter. Cardinal Health expects to resolve the impact of inflationary pressures and global supply-chain constraint by the end of fiscal 2024, paving a path for strong recovery in margins going forward. The company’s focus on promoting Cardinal Health brand volumewith a 5-point plan is likely to boost its prospect this financial year.

• A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return.
• The company continues to face high costs support sales as well as rising operating expenses.
• Style is an investment factor that has a meaningful impact on investment risk and returns.
• ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

Many investors continue to look for growth wherever they can find it. It’s interesting that Sprecher seeks to restore the bonds of loyalty homeowners once felt for their neighborhood banks. If it works, it’ll lower costs for consumers—and mean big profits for ICE.

NYSE: UNH

In the fourth quarter of fiscal 2023, pharmaceutical revenues totaled $49.7 billion, up 15% on a year-over-year basis. The performance highlights branded pharmaceutical sales growth from existing Pharmaceutical distinguish between economies of scale and economies of scope. Distribution and Specialty Solutions customers. The Barchart Technical Opinion widget shows you today's overally Barchart Opinion with general information on how to interpret the short and longer term signals.

Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer. IRVING, Texas–(BUSINESS WIRE)– #ACOs–Lightbeam Health Solutions, the leader in population health enablement solutions and services, today announces an expanded collaboration to deliver more solutio… The stock has rallied 12.2% year to date compared with the industry’s 12% growth. McKesson, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 10.7%. MCK’s earnings surpassed estimates in three of the trailing four quarters and missed once, delivering an average surprise of 8.1%.

Strong demand across product categories, brand, specialty, consumer health and generics drove the top line for Cardinal Health’s Pharma segment in the last reported quarter. GLP-1 medications were an increasing contributor to the top line in the last couple of quarters that is likely to rise significantly going forward. Shares of this Zacks Rank #3 (Hold) company have risen 15.5% year to date compared with the industry's 12% growth.

Is Cardinal Health (CAH) a Fairly Valued Stock? An In-depth Analysis

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.32% per year. These returns cover a period from January 1, 1988 through July 31, 2023.

They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends. Cardinal Health is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $190 billion in annual U.S. drug distribution sales in fiscal year 2023, the company supplies roughly a quarter of the overall market. Together, the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the U.S. market.

Cardinal Health Return vs. S&P

The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.

Based on an average trading volume of 2,320,000 shares, the days-to-cover ratio is currently 4.6 days. Cardinal Health's stock was trading at $76.87 on January 1st, 2023. Since then, CAH shares have increased by 14.4% and is now trading at $87.94.

Vlad Tenev, Robinhood’s CEO, expressed optimism about the company's future, emphasizing its commitment to innovation and growth. Indeed, Sprecher notes that today, ICE is handling around 10% of all end-to-end home loan production on its digital platform. “That’s an increase from virtually zero mortgages handled electronically a few years ago,” he adds. He believes that once the Black Knight platform is fully integrated, ICE will be able to substantially reduce today’s typical cost of $8,000 or more, and cut the time from origination to closing to as little as a few days. Cardinal Health saw a increase in short interest in August. As of August 31st, there was short interest totaling 10,680,000 shares, an increase of 107.0% from the August 15th total of 5,160,000 shares.

How big is Cardinal Health Inc?

Provides a general description of the business conducted by this company. CAH earnings call for the period ending September 30, 2021. If the tide runs out, you won't be caught swimming naked with these two stocks in your portfolio.

Data may be intentionally delayed pursuant to supplier requirements. In an exclusive interview, Wood expressed satisfaction with DraftKings' performance over the past years, highlighting its diversification into areas like non-fungible tokens and its strong position alongside FanDuel. Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next days. Some better-ranked https://1investing.in/ stocks in the broader medical space are Align Technology (ALGN Quick QuoteALGN – Free Report) , HealthEquity, Inc. (HQY Quick QuoteHQY – Free Report) and McKesson Corporation (MCK Quick QuoteMCK – Free Report) . Cardinal Health Inc. (CAH Quick QuoteCAH – Free Report) is well poised for growth, given its acquisition-driven strategy, a diversified product portfolio and a robust pharmaceutical segment.